Lactobacillus Rhamnosus sepsis in a preterm infant associated with probiotic integrator use: A case report;Sepsi da Lactobacillus Rhamnosus associato all'utilizzo di un integratore probiotico in un neonato pretermine: case report

Recenti Progressi in Medicina

Volumn 107, Issue 9, 2016, Pages 485-486

  Molinaro, Manuela ^a   Aiazzi, Massimo ^a   La Torre, Antonio ^a   Cini, Elisabetta ^a   Banfi, Roberto ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Enterecolitis; Probiotics; Prophylaxis; Side effects; Supplementation

Indexed keywords

ANTIBIOTIC AGENT; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PROBIOTIC AGENT;

ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HIGH RISK PATIENT; HUMAN; INFANT; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS SEPSIS; NECROTIZING ENTEROCOLITIS; NEWBORN SEPSIS; PREMATURITY; PROPHYLAXIS; REMISSION; NEWBORN; SEPSIS;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; SEPSIS;

EID: 85019605074     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: 10.1701/2354.25230     Document Type: Article

References (11)

1. Cortese F, Scicchitano P, Gesualdo M, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol 2015 Dec 2 pii; S1875-9572(15)00175-8.
2. Manzoni P, Decembrino L, Gallo E, et al. Nuove strategie di prevenzione delle infezioni nel neonato pretermine. Recenti Prog Med 2010; 101: 483-9.
3. Kochan P, Chmielarczyk A, Szymaniak L, et al. Lactoba-cillus rhamnosus administration causes sepsis in a car-diosurgical patient: is the time right to revise probiotic safety guidelines? Clin Microbiol Infect 2011; 17: 1589-92.
4. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gas-troenterol 2013; 47: 437-9.
5. Farina C, Arosio M, Mangia M, Moioli F. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcer-ative colitis. J Clin Gastroenterol 2001; 33: 251-2.
6. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24: 278-80.
7. Zein EF, Karaa S, Chemaly A, Saidi I, Daou-Chahine W, Rohban R. Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report. Ann Biol Clin (Paris) 2008; 66: 195-8.
8. Notario R, Leardini N, Borda N, Gambandé T, Cerutti H. Hepatic abscess and bacteremia due to Lactobacillus rhamnosus. Rev Argent Microbiol 2003; 35: 100-1.
9. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactoba-cillus bacteremia, clinical signifcance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004; 38: 62-9.
10. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82: 103-8.
11. Roe AL, Paine MF, Gurley BJ, Brouwer KR, Jordan S, Grifths JC. Assessing natural product-drug interactions: an end-to-end safety framework. Regul Toxicol Pharmacol 2016; 76: 1-6.